血管内取栓决策可视化辅助工具
研究基于患者层面汇总的随机试验数据,生成100人图标阵列,展示血管内取栓对急性大血管闭塞性缺血性卒中的获益与风险。结果显示,取栓联合静脉tPA的获益需治疗人数为2.9,单纯取栓为2.3;危害需治疗人数分别为68.9和100。可视化工具可快速教育医患双方。
要点
- 取栓联合tPA的获益需治疗人数为2.9,危害需治疗人数为68.9。
- tPA禁忌患者单纯取栓的获益需治疗人数为2.3,危害需治疗人数为100。
- 可视化工具可快速展示获益与风险,辅助临床决策。
核心结论
- 可视化决策辅助工具可用于快速教育医护人员、患者及家属,展示取栓联合tPA或单纯取栓的获益与风险。
研究设计与样本
- 基于患者层面汇总的随机试验数据,生成100人图标阵列,采用自动化算法和专家引导的联合结局表两种方式展示取栓效果。
主要发现
- 取栓联合tPA的获益需治疗人数为2.9(95%CI 2.6-3.3),危害需治疗人数为68.9(95%CI 40-250)。
- tPA禁忌患者单纯取栓的获益需治疗人数为2.3(95%CI 2.1-2.5),危害需治疗人数为100(95%CI 62.5-250)。
- 取栓联合tPA时,100例中34例残疾结局改善,包括14例恢复正常或接近正常(mRS 0-1)。
- tPA禁忌患者单纯取栓时,100例中44例残疾结局改善,包括16例恢复正常或接近正常。
- 两种人群均有1/100患者出现危害(mRS残疾增加),由新发区域梗死增加介导。
临床怎么用
- 临床中可使用该可视化工具向患者及家属快速展示取栓的获益与风险,辅助决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Rapid decision making optimizes outcomes from endovascular thrombectomy for acute cerebral ischemia. Visual displays facilitate swift review of potential outcomes and can accelerate decision processes. METHODS: From patient-level, pooled randomized trial data, 100 person-icon arrays (Kuiper-Marshall personographs) were generated showing beneficial and adverse effects of endovascular thrombectomy for patients with acute cerebral ischemia and large vessel occlusion using (1) automated (algorithmic) and (2) expert-guided joint outcome table specification. RESULTS: For the full 7-category modified Rankin Scale, thrombectomy added to IV tPA (intravenous tissue-type plasminogen activator) alone had number needed to treat to benefit 2.9 (95% confidence interval, 2.6-3.3) and number needed to harm 68.9 (95% confidence interval, 40-250); thrombectomy for patients ineligible for IV tPA had number needed to treat to benefit 2.3 (95% confidence interval, 2.1-2.5) and number needed to harm 100 (95% confidence interval, 62.5-250). Visual displays of treatment effects on 100 patients showed: with thrombectomy added to IV tPA alone, 34 patients have better disability outcome, including 14 more normal or near normal (modified Rankin Scale, 0-1); with thrombectomy for patients ineligible for IV tPA, 44 patients have a better disability outcome, including 16 more normal or nearly normal. Displays also showed that harm (increased modified Rankin Scale final disability) occurred in 1 of 100 patients in both populations, mediated by increased new territory infarcts. The person-icon figures integrated these outcomes, and early side-effects, in a single display. CONCLUSIONS: Visual decision aids are now available to rapidly educate healthcare providers, patients, and families about benefits and risks of endovascular thrombectomy, both when added to IV tPA in tPA-eligible patients and as the sole reperfusion treatment in tPA-ineligible patients.
引用
- Tokunboh I, Vales Montero M, Zopelaro Almeida MF, et al. Visual Aids for Patient, Family, and Physician Decision Making About Endovascular Thrombectomy for Acute Ischemic Stroke. Stroke. 2017. PMID: 29222229. doi:10.1161/STROKEAHA.117.018715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。